Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 17;39(4):411-415.
doi: 10.1055/s-0042-1758076. eCollection 2022 Aug.

Oncopharmacology in Interventional Radiology

Affiliations
Review

Oncopharmacology in Interventional Radiology

Junaid Raja et al. Semin Intervent Radiol. .

Abstract

The broad scope of malignancies treated in interventional oncology is mirrored by the breadth of oncotherapeutics, drugs used to treat cancer. Many of these treatments are administered endovascularly, though a group of therapies can be delivered percutaneously. Perhaps the best taxonomy of oncotherapeutics is based on their biological inactivity or activity and the mechanism by which they interact with treated and targeted tissues. As the fields of interventional oncology and oncotherapeutics continue to grow and expand, this framework may provide a more organized approach in helping distinguish and select the best therapy for patients.

Keywords: chemotherapy; endovascular; interventional radiology; oncology; oncotherapeutics; percutaneous.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

References

    1. Ramsey D E, Kernagis L Y, Soulen M C, Geschwind J F.Chemoembolization of hepatocellular carcinoma J Vasc Interv Radiol 200213(9, Pt 2):S211–S221. - PubMed
    1. Van Ha T G. Transarterial chemoembolization for hepatocellular carcinoma. Semin Intervent Radiol. 2009;26:270–275. - PMC - PubMed
    1. Marelli L, Stigliano R, Triantos C. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol. 2007;30(01):6–25. - PubMed
    1. Case M D, Slovak R, Raja J, Kim H S. Interventional Oncology in Immuno-Oncology Part 2: Transcatheter therapies. Dig Dis Interv. 2019;03(02):155–162.
    1. Sheth R A, Sabir S, Krishnamurthy S. Endovascular embolization by transcatheter delivery of particles: past, present, and future. J Funct Biomater. 2017;8(02):12. - PMC - PubMed